Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 51407-564

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 51407-564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gsms, Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstruchtcz (Chemstruchtcz)

Chemical structure of the active ingredient shown, featuring a benzene ring with chloro, sulfonamide, and a sulfonamide-containing heterocyclic substituent. This structure likely represents one component related to the active ingredients in the product LISINOPRIL and HYDROCHLOROTHIAZIDE.*

FDA Label Image

Chemstruclisinopril (Chemstruclisinopril)

Chemical structure diagram of lisinopril, showing atoms, bonds, and stereochemistry, including the presence of two water molecules as hydrate (2H2O).*

FDA Label Image

Containerlabel10n12p5mg500cc (Containerlabel10n12p5mg500cc)

Label for Lisinopril and Hydrochlorothiazide Tablets USP 10 mg/12.5 mg, oral tablets in a package of 500 tablets. The label includes dosage strength, storage instructions, manufacturer CorePharma LLC in New Jersey, and labeler GSMS Incorporated. It also features a serialization area and barcode.*

FDA Label Image

Containerlabel10n12p5mg90cc (Containerlabel10n12p5mg90cc)

Label for Lisinopril and Hydrochlorothiazide Tablets, USP 10 mg/12.5 mg, oral tablet form. The label shows a quantity of 90 tablets. It includes dosage strength, manufacturer CorePharma LLC, marketer GSMS Incorporated, and storage warnings. A serialization area measuring 1"x1.5" is on the right side.*

FDA Label Image

Containerlabel20n12p5mg500cc (Containerlabel20n12p5mg500cc)

Label for Lisinopril and Hydrochlorothiazide Tablets, USP 20 mg/12.5 mg by GSMS Incorporated. The oral tablet packaging holds 500 tablets. The label includes dosage information, storage warnings, manufacturer details (CorePharma, LLC), and a serialization area on the right.*

FDA Label Image

Containerlabel20n12p5mg90cc (Containerlabel20n12p5mg90cc)

Label for Lisinopril and Hydrochlorothiazide Tablets, USP 20 mg/12.5 mg, oral tablet form. The label indicates 90 tablets per bottle, with GSMS Incorporated as the marketer and CorePharma, LLC as manufacturer. It includes usage warnings and storage instructions, plus a barcode and serialization area.*

FDA Label Image

Containerlabel20n25mg500cc (Containerlabel20n25mg500cc)

Label for Lisinopril and Hydrochlorothiazide Tablets, USP 20 mg/25 mg, oral tablets in a package of 500 tablets. The label shows the product name, strength, quantity, and manufacturer as GSMS Incorporated. It includes storage warnings and dispensing instructions, with serialization area on the right side.*

FDA Label Image

Containerlabel20n25mg90cc (Containerlabel20n25mg90cc)

The packaging label for Lisinopril and Hydrochlorothiazide Tablets, USP, shows a strength of 20 mg lisinopril and 25 mg hydrochlorothiazide per tablet. The label indicates a count of 90 tablets, marked by GSMS Incorporated, and manufactured by CorePharma, LLC. It includes storage instructions, dosage reference, and a serialization area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.